Clinical Evaluation of the Infinity Deep Brain Stimulation System

CompletedOBSERVATIONAL
Enrollment

234

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

August 7, 2019

Study Completion Date

April 19, 2022

Conditions
Parkinson Disease
Interventions
DEVICE

Omnidirectional stimulation

At the 3-month follow-up, therapeutic window, symptom relief and side effect thresholds are evaluated at the best level for omnidirectional stimulation with the Infinity DBS lead.

DEVICE

Directional stimulation

At the 3-month follow-up, therapeutic window, symptom relief and side effect thresholds are evaluated using directional contacts at the best segmented level of the Infinity DBS lead.

Trial Locations (41)

1307

Carl Gustav Carus Dresden an der Technischen, Dresden

2145

Westmead Hospital, Richmond

3050

Royal Melbourne Hospital - City Campus, Melbourne

4102

Princess Alexandra Hospital, Brisbane

10016

New York University Langone Medical Center - Tisch Hospital, New York

10019

Mount Sinai Hospital, New York

12208

Albany Medical Center, Albany

15212

Allegheny General Hospital - ASRI, Pittsburgh

18015

St. Luke's Hospital & Health Network, Bethlehem

19107

Pennsylvania Hospital, Philadelphia

Thomas Jefferson University Hospital, Philadelphia

20161

IRCCS Istituto Ortopedico Galeazzi, Milan

20246

UKE Hamburg, Hamburg

21287

Johns Hopkins University Hospital, Baltimore

27100

Fondazione Istituto Neurologico Nazionale C. Mondino, Pavia

32610

Shands at University of Florida, Gainesville

33011

Hospital Universitario Central de Asturias, Department of Neurology,, Oviedo

33100

Azienda Ospedaliero-Universitaria S Maria della Misericordia, Udine

33136

University of Miami Hospital, Miami

40225

Heinrich Heine University of Düsseldorf, Department of Neurology, Düsseldorf

41013

Hospital Universitario Virgen del Rocío, Department of Neurology, Seville

42100

UZ Gent, Ghent

43210

Ohio State Medical, Columbus

44195

The Cleveland Clinic Foundation, Cleveland

55131

Johannes Gutenberg-University of Mainz, Mainz

60612

Rush University, Department of Neurological Sciences, Chicago

66160

Kansas University Medical Center, Kansas City

75024

Abbott, Medical and Clinical Affairs, Plano

75251

Neurology Consultants of Dallas, Dallas

77030

CHI St. Luke's Health Baylor College of Medicine Medical Center, Houston

80045

University of Colorado Hospital, Aurora

93053

Klinikum der Universität Regensburg, Regensburg

95825

Kaiser Permanente Sacramento Medical Center, Sacramento

97239

Oregon Health and Science University, Department of Neurology, Portland

08901

Robert Wood Johnson University Hospital, New Brunswick

Unknown

Heinrich-Heine-Universität Düsseldorf, Department of Functional and Stereotactic Neurosurgery, Düsseldorf

80-803

Copernicus Hospital, Department of Neurosurgery,, Gdansk

02-781

Oncology Center- Marie Curie Institute, Warsaw

02-957

Institute of Psychiatry and Neurology, Warsaw

08916

Hospital Universitari Germans Trias I Pujol, Badalona

L9 7LJ

The Walton Centre, Liverpool

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT02989610 - Clinical Evaluation of the Infinity Deep Brain Stimulation System | Biotech Hunter | Biotech Hunter